SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
CannLabs, Inc. (CANL) trades at a trailing P/E of 0.1. Trailing earnings yield is 1,111.11%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.1); earnings yield beats bond yields (1,111.11%).
- Trailing Earnings Yield 1,111.11% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 78/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CANL
Valuation Multiples
P/E (TTM)0.1
Forward P/EN/A
PEG Ratio0.00
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.01
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1,111.11%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$0.00 |
$146.15K |
$-27.78K |
-19% |
| 2013 |
$0.00 |
$84.3K |
$-79.03K |
-93.7% |
| 2014 |
$-0.03 |
$1.36M |
$-1.58M |
-116.1% |
| 2016 |
$-0.03 |
$1.36M |
$-1.58M |
-116.1% |
| 2017 |
$-0.03 |
$1.36M |
$-1.58M |
-116.1% |
| 2018 |
$-0.03 |
$1.36M |
$-1.58M |
-116.1% |
| 2019 |
$0.01 |
$2.5M |
$803.58K |
32.2% |
| 2020 |
$0.00 |
$2.77M |
$520.57K |
18.8% |
| 2021 |
$0.00 |
$3.18M |
$712.8K |
22.4% |
| 2022 |
$0.00 |
$4.39M |
$869.17K |
19.8% |
